Glycoconjugates in normal and abnormal secondary neurulation.
In chick embryos, the anterior greater portion of the neural tube develops by the folding, apposition, and fusion of the neuroectoderm. The smaller caudal portion that forms the secondary neural tube (lumbosacral and coccygeal regions) is derived from the tail bud, an aggregate of mesenchymal cells located at the caudal limit of the body. Tail bud mesenchyme, arranged in a solid cord, undergoes mesenchymal-epithelial transformation to form the secondary neural tube. Previous evidence suggests that this transformation is accompanied by modulation of cell surface glycoconjugates in the differentiating tissues. In this study, we show by lectin histochemistry and lectin blotting of proteins isolated by SDS-PAGE, that Datura stramonium agglutinin (DSA) binds preferentially to differentiating tail bud cells. This lectin is specific for beta 1-4-linked N-acetylglucosamine oligomers, such as the oligosaccharides of the poly-N-acetyllactosamine series that have been previously implicated in cell differentiation. Ultrastructural lectin cytochemistry indicates that at least some of the proteins binding DSA are localized extracellularly. The use of DSA as a teratogen resulted in embryos showing a variety of neural tube and notochord defects. We have also examined the binding of DSA to embryos that were treated with teratogenic doses of retinoic acid by sub-blastodermal injection, and find that the DSA-binding patterns are perturbed. Analysis of DSA-treated embryos using the TUNEL technique indicated that cell death was not a factor in DSA teratogenesis. This strongly suggests that the glycoconjugates of the cell surface have a role in the normal differentiation of tail bud mesenchyme into the neuroepithelium of the secondary neural tube. Perturbations of glycoconjugate activity results in defects of the secondary neural tube and associated tail bud derivatives.
Griffith
C M
CM
Department of Anatomy and Neurobiology, University of Ottawa, Ontario, Canada.
Hsieh
T
T
Smith
C
C
Sanders
E J
EJ
D000014:Abnormalities, Drug-Induced; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D002642:Chick Embryo; D004249:DNA Damage / Q000187:drug effects; D004591:Electrophoresis, Polyacrylamide Gel; D005109:Extracellular Matrix / Q000502:physiology; D006001:Glycoconjugates / Q000502:physiology*; D007150:Immunohistochemistry / Q000379:methods; D037102:Lectins / Q000633:toxicity; D008565:Membrane Proteins / Q000096:biosynthesis; D016253:Microscopy, Immunoelectron; D009420:Nervous System / Q000196:embryology*; D009421:Nervous System Malformations; D009436:Neural Tube Defects / Q000139:chemically induced; D009672:Notochord / Q000002:abnormalities; D013534:Survival; D013623:Tail / Q000002:abnormalities / Q000196:embryology / Q000648:ultrastructure; D014212:Tretinoin / Q000633:toxicity
D006001:Glycoconjugates; D037102:Lectins; D008565:Membrane Proteins; D014212:Tretinoin